rxstat › Classes › Dopaminergic Agents

Dopaminergic Agents: shortage status in Canada

6 of the 6 dopaminergic agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Widespread shortageRasagiline4 of 7 reported products affected · est. return Jul 31, 2026Partial shortageCarbidopa Levodopa4 of 21 reported products affected · est. return Nov 30, 2026Partial shortageEntacapone1 of 4 reported products affected · est. return Jul 20, 2026Partial shortagePramipexole Dihydrochloride4 of 40 reported products affected · est. return Sep 4, 2026Partial shortageRopinirole5 of 23 reported products affected · est. return Aug 10, 2026Partial shortageSelegiline1 of 3 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.